QIMR Berghofer

PDGFIR beta blockade bypasses resistance to combined MEK1/2-JAK2 inhibition in triple-negative breast cancer via intratumoral CD8+T-cells infiltration

Authors Kalimutho, Murugan; Khanna, Kum Kum
Journal CANCER RESEARCH
Pages
Volume 79
Date 1/07/2019
Grant ID
Funding Body
URL http://www.ncbi.nlm.nih.gov/pubmed/?term=10.1158/1538-7445.AM2019-LB-256